The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab
ConditionDiabetes Mellitus, Type 2
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorHanlim Pharm. Co., Ltd.
About this trial
This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinical practice.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults over 19 years of age
Individuals diagnosed with type 2 diabetes.
Individuals who, at the clinical discretion, are prescribed Tenero Tab or Tenero M SR Tab for the purpose of diabetes treatment for the first time.
Individuals who have voluntarily provided written consent to participate in this study.
Disqualifiers
Pregnant or breastfeeding women.
Individuals who are contraindicated according to the approved indications of Tenero Tab/Tenero M SR Tab.
Other cases where the principal investigator and study personnel deem individuals ineligible for participation in this clinical trial.
Trial population
Patients prescribed Tenero Tab/Tenero M SR Tab for diabetes treatment.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Change in HbA1c at 6 months of prescribing Tenero Tablet/Tenero Emextended Release Tablet compared to baseline
Change in HbA1c at 6 months of prescribing Tenero Tablet/Tenero Emextended Release Tablet compared to baseline
Time frame
after 6 months of prescription for Tenero Tab/Tenero M SR Tab compared to baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov